Infection that occurs in Indonesia has increased more significantly than before, compared to the increasing bacterial multidrug resistance (MDR) as the cause of infection. A study conducted in 5 hospitals in Indonesia in 2013 showed that the prevalence rate of extended-spectrum β-lactamase (ESBL)-producing bacteria reached 32-68%. The objective of this study is to detect the prevalence and resistence pattern of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Dr. Zainoel Abidin General Hospital, Banda Aceh. This study was conducted from 1 September 2016 to 31 December 2016. Specimen types included in this study were blood, sputum, urine, pus, mucosal swab, and another body fluids sample. The sampling method in this study was total sampling that is all clinical specimen examined in Clinical Microbiology Laboratory. Isolation and identification ESBL-producing bacteria was performed by VITEK-2 machine (Biomerieux). The result of this study is that a total 122 E. coli and K. pneumoniae were isolated. That consisted of 48 (39%) E. coli isolates and 74 (61%) K. pneumoniae isolates. From 48 E. coli isolates it was found out that 41 (85%) had ESBL phenotypes and from 74 K. pneumoniae isolates it was found out that 59 (80%) had ESBL phenotypes. In total, 100 (82%) isolates from 122 isolates had ESBL phenotypes. Distribution of ESBL-producing E. coli and K. pneumoniae based on sample was 24 (89%) isolates from the total of 27 urine isolates, 18 (95%) isolates from the total of 19 blood isolates, 28 (78%) isolates from the total of 36 sputum isolates, and 30 (75%) isolates from the total of 40 pus isolates. Antibiotic sensitivity pattern of the E. coli and K. pneumoniae isolates had high sensitivity to amycasin dan meropenem which was above 89%. Meanwhile, it also had sensitivity to Fosfomycin and Piperacyclin-Tazobactam by 80% and 77% respectively. Another antibiotic was less effective.
Introduction
Infectious diseases in Indonesia still need special attention. This happens due to the increasing resistence and multiresistance of bacteria which often become the cause of infection and these can come from hospitals (nosocomial infection) or the community. A study conducted in 5 hospitals in Indonesia in 2013 shows that the prevalence level of ESBL producing bacteria reached 32-68% (Kuntaman, 2013) . This shows the high handling problems of infectious diseases facing the health care system in Indonesia. Surveillance of ESBL-producing bacteria incidence in dr. Zainoel Abidin General Hospital has never been done, even though dr. Zainoel Abidin General Hospital is a referral hospital of Aceh province. These surveillance data are important to know the trend of resistant bacteria numbers especially ESBL-producing bacteria so that preventional planning can be made. Some research with the same study area has been conducted in several educational hospitals in Indonesia. Some studies with the theme of ESBL-producing bacteria in Indonesia include Kuntaman et al., 2006; Herwana et al., 2008; Winarto. 2009; Severin et al., 2010; Pajariu et al., 2010; Kuntaman et al., 2011; Yuwono. 2011; Severin et al., 2012; Bramantono et al., 2013; Keiko et al., 2013; Warganegara et al., 2014; Fatmawati et al., 2015 . Therefore, this research needs to be done to know the incidence and the sensitivity pattern of Extended Spectrum Beta Lactamase (ESBL)-bacteria producing Escherichia coli and Klebsiella pneumoniae in dr. Zainoel Abidin General Hospital.
Materials and Methods
This research was conducted in Microbiology Clinic Laboratory of dr. Zainoel Abidin General Hospital Banda Aceh. The time for the research began on 1 September and finished on 30 December 2016. The sample of this study was a clinical specimen form of urine, blood, sputum, and pus. Targeted bacteria were ESBL-producing Escherichia coli and Klebsiella pneumoniae that grew from cultures. Verification of bacteria as the cause of infection was done by checking the medical record or checking the patient directly according to the expertise by Clinical Microbiology Specialists or doctors with infectious disease specificity. Bacteria which grow from chronic wound specimen (like diabetic ulcer) or burn wound with secondary infection was excluded.
Bacteria isolation, identification, and sensitivity test
Isolation of bacteria was done in Mc Conkey media. The media was put in an incubator at a temperature of 37°C for 24 hours. All growing bacteria were identified with Vitex2 automatic machine. An inspection using automatic machine is a standard for bacterial identification and sensitivity testing by VITEK-2 (Biomerieux). A periodic quality control, twice weekly, was performed using Escherichia coli ATCC 25922 and Klebsiella pneumoniae ATCC 700603 (for ESBL-producing bacteria control). ESBLproducing Escherichia coli and Klebsiella pneumonia determined based on the results of ceftazidim or cefotaxime antibiotic sensitivity test on vitex-2 machine shows a resistant result. The sensitivity test results of each antibiotic for ESBL-producing bacteria were performed by dividing the number of sensitive and intermediate antibiotic results which were divided by all isolates examined, in a percentage.
Data collection
The data of each isolate were collected in the data collection sheet and entered into the SPSS file then followed by analysis and discussion. All Escherichia coli and Klebsiella pneumonia were accounted for the amount and sensitivity to antibiotics according to machine diagnostic protocols. The incidence of ESBL-producing Escherichia coli and Klebsiella pneumonia bacteria was the number of all ESBLproducing bacteria divided by the total of Escherichia coli and Klebsiella pneumonia. Calculations were performed for each Escherichia coli and Klebsiella pneumonia and total calculation.
Results and Discussion
The result of identification of Escherichia coli and Klebsiella pneumonia from clinical specimen in dr. Zainoel Abidin General Hospital Banda Aceh was that there were 122 isolates with 48 (39%) E. coli isolates and 74 (61%) K. pneumoniae isolates (Table 1) . 
Result of Sensitivity test of ESBL and non-ESBL producing Escherichia coli and

Klebsiella pneumonia
The results of the antibiotic sensitivity test of Escherichia coli and Klebsiella pneumonia show that amikacin and meropenem had the highest sensitivity of 94% and 89% respectively. Next was followed by Fosfomycin and Piperacillin- Tazobactam with 80% and 77%, respectively, while other antibiotics had a sensitivity level below 70% (Table 3) .
From the total of 122 E. coli and K. pneumoniae there were isolates consisting of 48 (39%) E. coli isolates and 74 (61%) K.pneumoniae isolates. From 48 E. coli isolates, there were 41 (85%) which had ESBL phenotypes and from 74 K.pneumoniae isolates there were 59 (80%) which had ESBL phenotypes. In total, 100 (82%) isolates from 122 isolates had ESBL phenotypes.
Distribution of ESBLproducing E. coli and K. pneumoniae based on sample was 24 (89%) isolates from the total of 27 urine isolates, 18 (95%) isolates from the total of 19 blood isolates, 28 (78%) isolates from the total of 36 sputum isolates, and 30 (75%) isolates from the total of 40 pus isolates.
The results of this study indicated that all samples obtained from clinical isolates in the Laboratory of Clinical Microbiology of dr. Zainoel Abdin General Hospital Banda Aceh were 122 samples. The total samples of identified E. coli were 48 samples and from all samples, 41 samples or 85% were ESBL producers. While the identified K. pneumoniae were 74 samples and from all samples, 59 samples or 80% were ESBL producers. Based on these data, there were more K. pneumoniae bacteria than E. coli and almost all E. coli and K. pneumoniae bacteria were ESBL producing bacteria. This is as explained by Souli, et al. (2008) , that K. pneumoniae is one of the most common gram-negative bacteria in multidrug resistence (MDR) problems.
Based on these data, blood samples were found to be the samples that had the highest percentage of ESBL-producing E. coli and K. pneumoniae bacteria. The results of this study were confirmed by testing the pattern of sensitivity of E. coli and K. pneumoniae to antibiotics. 
